Ensign vs Sonida Senior Living
ENSG and SNDA side by side, both in health services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ENSG and SNDA compare
Ensign is the larger company, worth 6.6 times as much as Sonida Senior Living ($10.9B against $1.6B).
Sonida Senior Living grew revenue faster over the last twelve months (49.4% versus 18.9% for Ensign).
Ensign keeps more of each dollar of sales as profit, with a net margin of 6.9% compared with −23.3% at Sonida Senior Living.
Ensign pays a dividend yielding 0.14%; Sonida Senior Living does not pay one.
Ensign scores higher on the StockData Score (19 against 4 for Sonida Senior Living), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ENSG | SNDA |
|---|---|---|
| Size and price | ||
| Market cap | $10.9B | $1.6B |
| Share price | $186.32 | $34.30 |
| Change, 1 year | 0.37% | 33.3% |
| Change, 5 years | 124% | 21.2% |
| Beta (5Y) | 0.46 | 0.60 |
| Employees | 46K | 5,140 |
| StockData Score | ||
| Total score | 19 (better) | 4 |
| Valuation score | 0 | 2 (better) |
| Growth score | 5 (better) | 2 |
| Performance score | 6 (better) | 0 |
| Health score | 5 (better) | 0 |
| Dividend score | 3 (better) | 0 |
| Valuation | ||
| P/E | 29.2× | – |
| P/S | 2.0× (better) | 3.1× |
| P/B | 4.4× | 1.9× (better) |
| EV/EBITDA | 18.4× (better) | 128× |
| PEG | 2.10 | – |
| FCF yield | – | −3.2% |
| Fair value | $151.76 | $37.39 |
| Margin of safety | −22.8% | 8.3% (better) |
| Growth | ||
| Revenue growth (TTM) | 18.9% | 49.4% (better) |
| Revenue growth, 5Y average | 16.1% (better) | −0.14% |
| Net income growth (TTM) | 17.3% | – |
| EPS growth (TTM) | 15.8% | – |
| EPS growth, 5Y average | 13.8% | – |
| Profitability | ||
| Gross margin | 20.7% | – |
| Operating margin | 8.5% | – |
| Net margin | 6.9% (better) | −23.3% |
| FCF margin | – | −10.0% |
| Return on equity | 17.0% (better) | −26.7% |
| Return on invested capital | 17.7% | – |
| Financial health | ||
| Debt / equity | 0.06 (better) | 1.82 |
| Net debt / EBITDA | −0.31 | 61.23 (better) |
| Interest coverage | 60.0× | – |
| Current ratio | 1.21 (better) | 0.88 |
| Altman Z-score | 3.71 (better) | 0.48 |
| Piotroski F-score | 6 (better) | 2 |
| Dividends and buybacks | ||
| Dividend yield | 0.14% | – |
| Payout ratio | 3.9% | – |
| Years of dividend growth | 15 | – |
| Dividend growth, 5Y average | 4.5% | – |
| Buyback yield | 0.37% (better) | −6.6% |
| Shareholder yield | 0.51% (better) | −6.6% |
| Ownership | ||
| Held by institutions | 90.6% | 78.4% |
| Held by insiders | 3.6% | 64.4% |
| Insider net buying, 12 months | −$13.6M | $89.0M (better) |
| Short interest, % of float | 2.6% | 20.6% |
Go deeper
- ENSG stock overview
- ENSG income statement
- ENSG valuation and score
- SNDA stock overview
- SNDA income statement
- SNDA valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.